Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

HPCL Stock Surges to Record Highs, Experts Advise Buying with Price Targets

Brokerage Reports

|

Updated on 04 Nov 2025, 02:12 am

Whalesbook Logo

Reviewed By

Simar Singh | Whalesbook News Team

Short Description :

Hindustan Petroleum Corporation Ltd (HPCL) has broken through a multi-month resistance zone to reach new record highs, trading above Rs 487 on November 3, 2025. Analysts cite strong technical indicators, including trading above key moving averages and bullish RSI and MACD. Experts recommend buying the stock for potential targets of Rs 545-560 within 3-4 weeks, with a stop-loss set at Rs 435.
HPCL Stock Surges to Record Highs, Experts Advise Buying with Price Targets

▶

Stocks Mentioned :

Hindustan Petroleum Corporation Ltd

Detailed Coverage :

Hindustan Petroleum Corporation Ltd (HPCL), a major player in the oil and gas sector, has achieved fresh record highs, surpassing Rs 487 on November 3, 2025, after breaking out of a significant multi-month resistance zone around Rs 450-460. The stock has shown robust performance, rallying over 19% in the last three months and experiencing a significant surge in trading volume, indicating strong investor interest. Technical analysis reveals HPCL is trading above crucial short and long-term moving averages, including the 200-DMA, and shows bullish signals from the Relative Strength Index (RSI) at 69.4 and the Moving Average Convergence Divergence (MACD). Rajesh Palviya from Axis Securities highlights that the breakout from the resistance zone and a rectangle pattern suggests persistent bullish momentum. He recommends buying HPCL on minor dips with a target price of Rs 545-560 and a stop-loss at Rs 435.

Impact: This strong technical breakout and positive expert recommendation could lead to increased investor buying, potentially driving the stock price higher towards the projected targets and boosting investor confidence in the company and the oil and gas sector. Rating: 8/10

Difficult Terms: Resistance Zone: A price level where a stock has historically found it difficult to move higher due to selling pressure. 200-DMA (200-Day Moving Average): An average of the stock's closing prices over the past 200 days, used as a long-term trend indicator. Momentum: The rate of acceleration of a stock's price change, indicating its upward or downward speed. RSI (Relative Strength Index): A technical indicator measuring the magnitude of recent price changes to evaluate overbought or oversold conditions. A reading above 70 is generally considered overbought, and below 30 oversold. MACD (Moving Average Convergence Divergence): A trend-following momentum indicator that shows the relationship between two moving averages of a stock's price, used to identify changes in momentum. Bullish Momentum: A sustained upward trend in stock prices characterized by increasing buying interest and price increases. Trading Volume: The total number of shares traded for a security during a given period, indicating market activity and interest. Rectangle Pattern: A consolidation chart pattern where prices trade within parallel horizontal support and resistance levels, often preceding a continuation of the prior trend.

More from Brokerage Reports

Stock recommendations for 4 November from MarketSmith India

Brokerage Reports

Stock recommendations for 4 November from MarketSmith India

Stocks to buy: Raja Venkatraman's top picks for 4 November

Brokerage Reports

Stocks to buy: Raja Venkatraman's top picks for 4 November

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Brokerage Reports

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Stock Radar: HPCL breaks out from a 1-year resistance zone to hit fresh record highs in November; time to book profits or buy?

Brokerage Reports

Stock Radar: HPCL breaks out from a 1-year resistance zone to hit fresh record highs in November; time to book profits or buy?

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Brokerage Reports

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

CDSL shares downgraded by JM Financial on potential earnings pressure

Brokerage Reports

CDSL shares downgraded by JM Financial on potential earnings pressure


Latest News

Lenskart IPO: Why funds are buying into high valuations

Tech

Lenskart IPO: Why funds are buying into high valuations

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth

Chemicals

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth

Snowman Logistics shares drop 5% after net loss in Q2, revenue rises 8.5%

Industrial Goods/Services

Snowman Logistics shares drop 5% after net loss in Q2, revenue rises 8.5%

Panama meetings: CBD’s new body outlines plan to ensure participation of indigenous, local communities

Environment

Panama meetings: CBD’s new body outlines plan to ensure participation of indigenous, local communities

Aviation regulator DGCA to hold monthly review meetings with airlines

Transportation

Aviation regulator DGCA to hold monthly review meetings with airlines

JM Financial downgrades BEL, but a 10% rally could be just ahead—Here’s why

Aerospace & Defense

JM Financial downgrades BEL, but a 10% rally could be just ahead—Here’s why


Banking/Finance Sector

IPPB to provide digital life certs in tie-up with EPFO

Banking/Finance

IPPB to provide digital life certs in tie-up with EPFO

MobiKwik narrows losses in Q2 as EBITDA jumps 80% on cost control

Banking/Finance

MobiKwik narrows losses in Q2 as EBITDA jumps 80% on cost control

Bajaj Finance's festive season loan disbursals jump 27% in volume, 29% in value

Banking/Finance

Bajaj Finance's festive season loan disbursals jump 27% in volume, 29% in value

LIC raises stakes in SBI, Sun Pharma, HCL; cuts exposure in HDFC, ICICI Bank, L&T

Banking/Finance

LIC raises stakes in SBI, Sun Pharma, HCL; cuts exposure in HDFC, ICICI Bank, L&T

Khaitan & Co advised SBI on ₹7,500 crore bond issuance

Banking/Finance

Khaitan & Co advised SBI on ₹7,500 crore bond issuance

CMS INDUSLAW acts on Utkarsh Small Finance Bank ₹950 crore rights issue

Banking/Finance

CMS INDUSLAW acts on Utkarsh Small Finance Bank ₹950 crore rights issue


Research Reports Sector

3M India, IOC, Titan, JK Tyre: Stocks at 52-week high; buy or sell?

Research Reports

3M India, IOC, Titan, JK Tyre: Stocks at 52-week high; buy or sell?

Mahindra Manulife's Krishna Sanghavi sees current consolidation as a setup for next growth phase

Research Reports

Mahindra Manulife's Krishna Sanghavi sees current consolidation as a setup for next growth phase

Sun Pharma Q2 preview: Profit may dip YoY despite revenue growth; details

Research Reports

Sun Pharma Q2 preview: Profit may dip YoY despite revenue growth; details

More from Brokerage Reports

Stock recommendations for 4 November from MarketSmith India

Stock recommendations for 4 November from MarketSmith India

Stocks to buy: Raja Venkatraman's top picks for 4 November

Stocks to buy: Raja Venkatraman's top picks for 4 November

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Vedanta, BEL & more: Top stocks to buy on November 4 — Check list

Stock Radar: HPCL breaks out from a 1-year resistance zone to hit fresh record highs in November; time to book profits or buy?

Stock Radar: HPCL breaks out from a 1-year resistance zone to hit fresh record highs in November; time to book profits or buy?

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

Ajanta Pharma offers growth potential amid US generic challenges: Nuvama

CDSL shares downgraded by JM Financial on potential earnings pressure

CDSL shares downgraded by JM Financial on potential earnings pressure


Latest News

Lenskart IPO: Why funds are buying into high valuations

Lenskart IPO: Why funds are buying into high valuations

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth

Mukul Agrawal portfolio: What's driving Tatva Chintan to zoom 50% in 1 mth

Snowman Logistics shares drop 5% after net loss in Q2, revenue rises 8.5%

Snowman Logistics shares drop 5% after net loss in Q2, revenue rises 8.5%

Panama meetings: CBD’s new body outlines plan to ensure participation of indigenous, local communities

Panama meetings: CBD’s new body outlines plan to ensure participation of indigenous, local communities

Aviation regulator DGCA to hold monthly review meetings with airlines

Aviation regulator DGCA to hold monthly review meetings with airlines

JM Financial downgrades BEL, but a 10% rally could be just ahead—Here’s why

JM Financial downgrades BEL, but a 10% rally could be just ahead—Here’s why


Banking/Finance Sector

IPPB to provide digital life certs in tie-up with EPFO

IPPB to provide digital life certs in tie-up with EPFO

MobiKwik narrows losses in Q2 as EBITDA jumps 80% on cost control

MobiKwik narrows losses in Q2 as EBITDA jumps 80% on cost control

Bajaj Finance's festive season loan disbursals jump 27% in volume, 29% in value

Bajaj Finance's festive season loan disbursals jump 27% in volume, 29% in value

LIC raises stakes in SBI, Sun Pharma, HCL; cuts exposure in HDFC, ICICI Bank, L&T

LIC raises stakes in SBI, Sun Pharma, HCL; cuts exposure in HDFC, ICICI Bank, L&T

Khaitan & Co advised SBI on ₹7,500 crore bond issuance

Khaitan & Co advised SBI on ₹7,500 crore bond issuance

CMS INDUSLAW acts on Utkarsh Small Finance Bank ₹950 crore rights issue

CMS INDUSLAW acts on Utkarsh Small Finance Bank ₹950 crore rights issue


Research Reports Sector

3M India, IOC, Titan, JK Tyre: Stocks at 52-week high; buy or sell?

3M India, IOC, Titan, JK Tyre: Stocks at 52-week high; buy or sell?

Mahindra Manulife's Krishna Sanghavi sees current consolidation as a setup for next growth phase

Mahindra Manulife's Krishna Sanghavi sees current consolidation as a setup for next growth phase

Sun Pharma Q2 preview: Profit may dip YoY despite revenue growth; details

Sun Pharma Q2 preview: Profit may dip YoY despite revenue growth; details